TWSTTwist Bioscience Corporation

$159.83+473% 1Y

Is the price fair?

What TWST's price assumes

Twist Bioscience Corporation did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 16.0× revenue.

16.0

Price / sales · no P/E: the last twelve months did not end in a profit

Price / book
12.7

Price / book · today's price, fiscal year to Sep 30, 2025

EV / sales
15.4

EV / sales

Details›
Price / booktoday's price, fiscal year to Sep 30, 2025
12.7
EV / EBIToperating margin −34%: the multiple describes the denominator
not meaningful
EV / salestoday's price, fiscal year to Sep 30, 2025
15.4
Market capitalisation
$6.02B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Most shorted stocks